Nitroglycerin Lingual Spray Recall Issued Over Defective Delivery System

The recalled sprays are used to alleviate chest pain in patients with coronary artery disease.

Three lots of Perrigo nitroglycerin spray are being recalled due to a risk that they may not dispense the medication properly to users suffering chest pains.

The Perrigo Nitroglycerin Lingual Spray recall was announced by the FDA on December 27 after the manufacturer received complaints that the device may not dispense its medication properly. However, there have been no reports of injuries linked to the recalled nitroglycerin spray.

Nitroglycerin is often used by patients with coronary artery disease to provide acute and fast relief or prevention of chest pain, known as angina pectoris. It is also used to treat heart attacks, but in IV form.

Nitroglycerin lingual spray is applied under or onto the tongue via a pump sprayer. According to the recall notice, there is a small risk that the pump will malfunction and fail to dispense the medication properly.

“If the product does not deliver the appropriate amount of nitroglycerin, the patient will likely continue to experience chest pain,” the recall notice warns. “The label advises that if relief is not obtained after 3 doses over 15 minutes the patient should promptly seek medical attention.”

Did You Know? Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

The recall affects Perrigo-brand Nitroglycerin Lingual Spray sold in 12g spray bottles, with an NDC number of 45802-210-02 sold in 400 mcg per spray strength. The recall includes lot number 150892 with an Oct 2022 expiration date; lot number 153199 with a Feb 2023 expiration date; and lot number 156041 with an Apr 2023 expiration date. The 4.9g spray bottles are not included in the recall.

The manufacturer is notifying all distributors and customers of the recall by express package delivery service and email and is arranging for the return of the recalled spray bottles. Padagis is asking all customers, healthcare providers and consumers to examine their inventory of Nitroglycerin Lingual Spray to see if the affected products are in their inventory,  and to immediately quarantine them, discontinue their distribution and return all recalled lots as directed.

Patients with the affected products are instructed to contact their healthcare provider for a replacement before returning the product.

Patients with questions about the recall can call 888-266-7912. Any adverse events should be reported to the FDA MedWatch Adverse Event Reporting program.

0 Comments

"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

LifeCell Hernia Mesh Lawsuit Filed After Strattice Tissue Matrix Failed
LifeCell Hernia Mesh Lawsuit Filed After Strattice Tissue Matrix Failed (Posted 3 days ago)

LifeCell faces a hernia mesh lawsuit after one of its Strattic Tissue Matrix mesh products failed in a South Carolina woman just a year after being implanted, requiring revision surgery.